Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MARS1 | P56192 | 1/20 | 0.82 |
| ▸ | SARS1 | P49591 | 1/20 | 0.81 |
| ▸ | RARS1 | P54136 | 1/20 | 0.81 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.80 |
| ▸ | TARS1 | P26639 | 2/20 | 0.77 |
| ▸ | IARS1 | P41252 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13773213 | 1.00 | MARS1 (0.82) | MARS1SARS1RARS1LARS1TARS1 | |
| SCHEMBL13773214 | 1.00 | MARS1 (0.82) | MARS1SARS1RARS1LARS1TARS1 | |
| SCHEMBL13773209 | 0.95 | MARS1 (0.84) | MARS1SARS1RARS1LARS1TARS1 | |
| SCHEMBL13773211 | 0.95 | MARS1 (0.84) | MARS1SARS1RARS1LARS1TARS1 | |
| SCHEMBL13773210 | 0.95 | MARS1 (0.84) | MARS1SARS1RARS1LARS1TARS1 | |
| SCHEMBL29390953 | 0.92 | SARS1 (0.81) | MARS1SARS1RARS1LARS1TARS1 | |
| SCHEMBL4253015 | 0.92 | SARS1 (0.81) | MARS1SARS1RARS1LARS1TARS1 | |
| SCHEMBL4308351 | 0.90 | MARS1 (1.00) | MARS1SARS1RARS1LARS1TARS1 | |
| SCHEMBL21067350 | 0.90 | MARS1 (1.00) | MARS1SARS1RARS1LARS1TARS1 | |
| SCHEMBL178820 | 0.90 | MARS1 (1.00) | MARS1SARS1RARS1LARS1TARS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8946188-B2 | Anti-microbial agents and uses thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2015-02-03 | — | — | US | disclosed |
| US-20140024611-A1 | ANTI-MICROBIAL AGENTS AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2014-01-23 | — | — | US | disclosed |
| US-8461128-B2 | Anti-microbial agents and uses thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2013-06-11 | — | — | US | disclosed |
| US-20090170805-A1 | ANTI-MICROBIAL AGENTS AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140024611-A1 | ANTI-MICROBIAL AGENTS AND USES THEREOF | ACAT1, ACAT2, APEH | MARS1 216/4885SARS1 722/4885RARS1 879/4885 |
| US-20090170805-A1 | ANTI-MICROBIAL AGENTS AND USES THEREOF | ACAT1, ACAT2, APEH | MARS1 216/4885SARS1 722/4885RARS1 879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.